Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.

Hexamethylenebisacetamide (HMBA), a potent inducer of differentiation of transformed cells such as murine erythroleukemia cells, causes a prolongation of the G1 phase of the cell cycle during which commitment to terminal differentiation is first detected. Removal of HMBA prior to the G1 phase aborts...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Kiyokawa, H, Richon, V M, Venta-Perez, G, Rifkind, R A, Marks, P A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC47009/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8341693/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.90.14.6746
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!